Kempczinski plans $8.7M Rule 144 stock sale

Christopher Kempczinski filed a Rule 144 notice to sell 26,276 shares of common stock through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $8,725,734.08.

Accepted by SEC EDGAR 02/13/2026 - 04:29 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Christopher Kempczinski filed a Rule 144 notice to sell 26,276 shares of common stock through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $8,725,734.08. The shares relate to a same-day cash exercise of stock options on 02/13/2026.

The notice also reports that 26,277 common shares were sold on 02/12/2026 under a Rule 10b5-1 trading plan for gross proceeds of $8,706,894.46. Shares outstanding were 712,154,350 as of the filing, providing context for the relative size of these transactions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares does Christopher Kempczinski plan to sell under this MCD Rule 144 filing?

Christopher Kempczinski plans to sell 26,276 common shares under this Rule 144 notice. These shares are to be sold through Morgan Stanley Smith Barney on the NYSE and have an aggregate market value of $8,725,734.08 based on the figures disclosed.

What is the value of the planned Rule 144 stock sale related to MCD?

The planned Rule 144 sale is valued at $8,725,734.08 for 26,276 common shares. This valuation comes from the aggregate market value disclosed in the filing for the proposed NYSE sale through Morgan Stanley Smith Barney.

How were the MCD shares in the Rule 144 filing acquired by Christopher Kempczinski?

The 26,276 common shares were acquired on 02/13/2026 through a cash exercise of stock options. The filing states the nature of the acquisition as “Exercise of Stock Options,” with payment made in cash on the same date as the acquisition.

What recent stock sales by Christopher Kempczinski are disclosed in this MCD-related filing?

The filing discloses a prior sale of 26,277 common shares on 02/12/2026 under a Rule 10b5-1 plan. Gross proceeds from that transaction were $8,706,894.46, providing context for recent trading activity over the past three months.

How many MCD common shares are outstanding compared with the shares in this Rule 144 sale?

The filing reports 712,154,350 common shares outstanding. The planned sale of 26,276 shares and the prior 26,277-share transaction are small compared with this outstanding share count, illustrating the limited relative size of these insider-related trades.

Does the Rule 144 filing for MCD mention a Rule 10b5-1 trading plan?

Yes. The filing’s three-month sales table lists “10b5-1 Sales for CHRISTOPHER KEMPCZINSKI” for 26,277 common shares sold on 02/12/2026. The remarks section also references reliance on Rule 10b5-1 trading plans when applicable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001598115
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MCDONALDS CORPORATION
SEC File Number	001-05231
Address of Issuer	110 North Carpenter Street Chicago ILLINOIS 60607
Phone	6306233000
Name of Person for Whose Account the Securities are To Be Sold	CHRISTOPHER KEMPCZINSKI
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	26276	8725734.08	712154350	02/13/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/13/2026	Exercise of Stock Options	Issuer			26276	02/13/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CHRISTOPHER KEMPCZINSKI 110 North Carpenter Street Chicago IL 60607	Common	02/12/2026	26277	8706894.46

144: Remarks and Signature

Remarks
Date of Notice	02/13/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/14/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Chris Kempczinski
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)